Search

Your search keyword '"Antineoplastic agents -- Physiological aspects -- Intellectual property"' showing total 5 results
Start Over Descriptor "Antineoplastic agents -- Physiological aspects -- Intellectual property"
5 results on '"Antineoplastic agents -- Physiological aspects -- Intellectual property"'

1. Researchers Submit Patent Application, 'Pharmaceutical Compositions And Combinations Comprising Inhibitors Of The Androgen Receptor And Uses Thereof', for Approval (USPTO 20240261282)

Subjects
Steroids -- Physiological aspects, Phenylbutazone -- Physiological aspects -- Intellectual property, Nilotinib -- Physiological aspects, Antineoplastic agents -- Physiological aspects -- Intellectual property, Antiviral agents -- Physiological aspects, Fluocinolone acetonide -- Physiological aspects, Anti-HIV agents -- Physiological aspects, Fluocinolone -- Physiological aspects, Physical fitness -- Physiological aspects, Antimitotic agents -- Physiological aspects -- Intellectual property, Tixocortol -- Physiological aspects, Darunavir -- Physiological aspects, Androgens -- Physiological aspects, Atazanavir -- Physiological aspects -- Intellectual property, Health
Abstract

2024 AUG 31 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]

Published
2024

2. Patent Issued for Bis-Diazeniumdiolate Compounds As Anti-Cancer Agents (USPTO 10,556,875)

Subjects
Cancer treatment -- Physiological aspects, Cancer -- Physiological aspects, Women's health -- Physiological aspects, Nitric oxide -- Physiological aspects -- Intellectual property, Antineoplastic agents -- Physiological aspects -- Intellectual property, Nitrogen oxides, Editors, Health, Women's issues/gender studies
Abstract

2020 FEB 27 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by [...]

Published
2020

3. 'Bis-Diazeniumdiolate Compounds As Anti-Cancer Agents' in Patent Application Approval Process (USPTO 20190106396)

Subjects
Antineoplastic agents -- Physiological aspects -- Intellectual property, Cancer -- Development and progression -- Physiological aspects, Nitric oxide -- Physiological aspects -- Intellectual property, Cancer treatment -- Physiological aspects, Women's health -- Physiological aspects, Women, Nitrogen oxides, Health, Editors, Health, Women's issues/gender studies
Abstract

2019 MAY 2 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventor Chen, Shengxi (Chandler, AZ), filed on October 9, [...]

Published
2019

4. '2,3-DIHYDROBENZO[b]THIOPHENE DERIVATIVES AS HYPOXIA INDUCIBLE FACTOR-2(ALPHA) INHIBITORS' in Patent Application Approval Process (USPTO 20220054451)

Subjects
Thiophene -- Physiological aspects, Antineoplastic agents -- Physiological aspects -- Intellectual property, Antimitotic agents -- Physiological aspects -- Intellectual property, Health
Abstract

2022 MAR 14 (NewsRx) -- By a News Reporter-Staff News Editor at Respiratory Therapeutics Week -- A patent application by the inventors FU, Jiping (Danville, CA, US); HE, Yigang (Newark, [...]

Published
2022

5. Patent Application Titled 'Marinopyrrole Derivatives as Anticancer Agents' Published Online

Subjects
Cancer treatment -- Physiological aspects, Apoptosis -- Physiological aspects, Patents -- Physiological aspects, Antineoplastic agents -- Physiological aspects -- Intellectual property, Patent/copyright issue, Health
Abstract

By a News Reporter-Staff News Editor at Clinical Trials Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by the inventors Li, Rongshi [...]

Published
2015

Catalog

Books, media, physical & digital resources
See catalog results